DISCLAIMER:
Entry of taxonomy/keywords during proffered abstract submission was optional.
Not all abstracts will appear in search results.
Taxonomy: IM- Radiation Dose and Risk: General (Most Aspects)
| MO-H345-IePD-F6-3 | Characterization of Fluoroscopy Radiation Dose Associated with the Administration of Y-90 Microspheres for Radioembolization Therapy X Nie*, K Recca, J Zhang, University of Kentucky, Lexington, KY |
| MO-J-BRA-0 | Managing Implanted Devices S Lim1*, S Kry2*, C Shi3*, M Chan4*, (1) Memorial Sloan-Kettering Cancer Center, Somerset, NJ, (2) The University of Texas MD Anderson Cancer Center, Houston, TX, (3) New York Proton Center, Edgewater, NJ, (4) Memorial Sloan Kettering Cancer Center, Basking Ridge, NJ |
| MO-J-BRA-1 | Dosimetric Concerns of Post-Mastectomy Tissue Expanders During External Beam Radiation Therapy S Lim1*, S Kry2*, C Shi3*, M Chan4*, (1) Memorial Sloan-Kettering Cancer Center, Somerset, NJ, (2) The University of Texas MD Anderson Cancer Center, Houston, TX, (3) New York Proton Center, Edgewater, NJ, (4) Memorial Sloan Kettering Cancer Center, Basking Ridge, NJ |
| MO-J-BRA-2 | Clinical Management of Cardiac Implantable Electronic Device (CIED) Patients S Lim1*, S Kry2*, C Shi3*, M Chan4*, (1) Memorial Sloan-Kettering Cancer Center, Somerset, NJ, (2) The University of Texas MD Anderson Cancer Center, Houston, TX, (3) New York Proton Center, Edgewater, NJ, (4) Memorial Sloan Kettering Cancer Center, Basking Ridge, NJ |
| MO-J-BRA-3 | Clinical Practices of Managing Implantable Medical Devices for Proton Therapy S Lim1*, S Kry2*, C Shi3*, M Chan4*, (1) Memorial Sloan-Kettering Cancer Center, Somerset, NJ, (2) The University of Texas MD Anderson Cancer Center, Houston, TX, (3) New York Proton Center, Edgewater, NJ, (4) Memorial Sloan Kettering Cancer Center, Basking Ridge, NJ |
| MO-J-BRA-4 | A Review of Managing Commonly Seen Implanted Devices for Radiotherapy Patients S Lim1*, S Kry2*, C Shi3*, M Chan4*, (1) Memorial Sloan-Kettering Cancer Center, Somerset, NJ, (2) The University of Texas MD Anderson Cancer Center, Houston, TX, (3) New York Proton Center, Edgewater, NJ, (4) Memorial Sloan Kettering Cancer Center, Basking Ridge, NJ |
| MO-J-BRA-5 | Q & A S Lim1*, S Kry2*, C Shi3*, M Chan4*, (1) Memorial Sloan-Kettering Cancer Center, Somerset, NJ, (2) The University of Texas MD Anderson Cancer Center, Houston, TX, (3) New York Proton Center, Edgewater, NJ, (4) Memorial Sloan Kettering Cancer Center, Basking Ridge, NJ |
| PO-GePV-M-71 | A Novel Dose-Volume Constraint to Reduce Toxicity Rates of the Parotid Glands for Head-And-Neck Cancer Patients H Choun1*, J Son2, S Kang2, H Jin2, E Yoon1, H Wu1; 2, J Park1;2 (1) Seoul National University, Seoul, KR, (2) Seoul National University Hospital, Seoul,KR |
| PO-GePV-M-75 | Monte-Carlo Dose Calculation System for Interventional Radiology (McDCIR) - Development and First Test H Han1*, S Moon1, G Son1, C Kim1, S Song2, (1) Hanyang University, Seoul, ,KR, (2) Hanyang University Medical Center, Seoul,KR |
| PO-GePV-T-94 | Investigation of KV Imaging Dose in Accelerated Partial Breast Irradiation (APBI) Y Song1*, X Zhai2, Y Liang3, B Mueller4, D Guttmann5, D Roth O'Brien6, L Braunstein7, (1) Memorial Sloan Kettering Cancer Center, Bergen, NJ,(2) Memorial Sloan Kettering Cancer Center, Bergen, NJ,(3) Memorial Sloan Kettering Cancer Center, Bergen, NJ,(4) Memorial Sloan Kettering Cancer Center, Bergen, NJ,(5) Memorial Sloan Kettering Cancer Center, Bergen, NJ,(6) Memorial Sloan Kettering Cancer Center, Bergen, NJ,(7) Memorial Sloan-Kettering Cancer Center, New York, NY |
| PO-GePV-T-188 | Accommodating a Proton PBS System in a Common Linac Vault- a Shielding Simulation D Fedorchenko1, S Alani1, S Koren1,2*, (1) Ziv Medical Center, Safed, IL,(2) Shaare Zedek Medical Center, Jerusalem, IL |
| PO-GePV-T-207 | Radiation Dose Tolerance of a Medtronic Deep Brain Stimulator Based On OSLD Measurement M Klash1*, S Klash2, E Mcclelland3, L Brennan4, J Grubic5, (1) KSEC, Belmont, Ohio, (2) VAPHS, Pittsburgh, PA, (3) VAPHS, Pittsburgh, PA, (4) VAPHS, Pittsburgh, PA, (5) VAPHS, Pittsburgh, PA |
| PO-GePV-T-212 | Radiation Dose Tolerance Assessment of the Zio Heart Monitor S Klash1*, L Brennan2, J Graham3, (1) VAPHS, Pittsburgh, PA, (2) VAPHS, Pittsburgh, PA, (3) VAPHS, Pittsburgh, PA |
| SU-J-201-4 | The Use of Hybrid Computational Phantoms to Estimate the Patient’s Peak Skin Dose During Fluoroscopically Guided Interventional Procedures (FGIPs) R Makkia*, M Fadhel, M Hoerner, D Vergara, Yale New Haven Hospital Department of Radiology and Biomedical Imaging and Yale University School of Medicine, New Haven, CT |
| SU-J-201-5 | Using Radiation Dose Structured Reports in the Patient Skin Dose Tracking System (DTS) for Fluoroscopically-Guided Interventional Procedures J Troville1,2, J Collins1,2, M Islam3, J Nosal3, J Woods3, A Syeda3, M Orji1,2, S Rudin1,2,3*, C Ionita1,2,3, D.R. Bednarek1,2,3, (1) University at Buffalo Department of Radiology, Buffalo, NY, (2) Canon Stroke and Vascular Research Center, Buffalo, NY, (3) University At Buffalo Department of Biomedical Engineering, Buffalo, NY |
| SU-K-201-6 | Computation of Gonadal Dose Irradiated From Urine Contaminated Diapers in Pediatric Patients During Renal Scintigraphy Exam Y Lu1*, S Kumbhar2, Y Liu1, N Vo1, M Baker3, J Qi1, (1) Medical College of Wisconsin, Milwaukee, WI, (2) Virginia Mason Medical Center, Seattle, WA, (3) Children Wisconsin, Milwaukee, WI |
| TU-D1000-IePD-F9-4 | Image Quality Preservation with Substantial Dose Reduction for Adults and Pediatric Patients Using New C-Arm CBCT Protocols S Brady*, N Hilvert, J Racadio, Cincinnati Childrens Hospital Med Ctr, Mason, OH |
| WE-FG-207-0 | Gonadal & Fetal Shielding Updates J Elee1*, Y Thakur2*, Q Moore3*, R Milman4*, (1) LA Dept of Environmental Qual, West Monroe, LA, (2) Vancouver Coastal Health Authority, Vancouver, BC, CA, (3) Mercy College of Ohio, Toledo, OH, (4) University of Colorado School of Medicine, Denver, CO |
| WE-FG-207-1 | Regulatory Implications of Changes in Patient Shielding Practices J Elee1*, Y Thakur2*, Q Moore3*, R Milman4*, (1) LA Dept of Environmental Qual, West Monroe, LA, (2) Vancouver Coastal Health Authority, Vancouver, BC, CA, (3) Mercy College of Ohio, Toledo, OH, (4) University of Colorado School of Medicine, Denver, CO |
| WE-FG-207-2 | Implementing Change in Patient Shielding Practices J Elee1*, Y Thakur2*, Q Moore3*, R Milman4*, (1) LA Dept of Environmental Qual, West Monroe, LA, (2) Vancouver Coastal Health Authority, Vancouver, BC, CA, (3) Mercy College of Ohio, Toledo, OH, (4) University of Colorado School of Medicine, Denver, CO |
| WE-FG-207-3 | A Technologist's View of Patient Shielding J Elee1*, Y Thakur2*, Q Moore3*, R Milman4*, (1) LA Dept of Environmental Qual, West Monroe, LA, (2) Vancouver Coastal Health Authority, Vancouver, BC, CA, (3) Mercy College of Ohio, Toledo, OH, (4) University of Colorado School of Medicine, Denver, CO |
| WE-FG-207-4 | Patient Shielding: What's Next? J Elee1*, Y Thakur2*, Q Moore3*, R Milman4*, (1) LA Dept of Environmental Qual, West Monroe, LA, (2) Vancouver Coastal Health Authority, Vancouver, BC, CA, (3) Mercy College of Ohio, Toledo, OH, (4) University of Colorado School of Medicine, Denver, CO |
| WE-FG-207-5 | Q & A J Elee1*, Y Thakur2*, Q Moore3*, R Milman4*, (1) LA Dept of Environmental Qual, West Monroe, LA, (2) Vancouver Coastal Health Authority, Vancouver, BC, CA, (3) Mercy College of Ohio, Toledo, OH, (4) University of Colorado School of Medicine, Denver, CO |